Risk Stratification in Pulmonary Embolism Based on Biomarkers and Echocardiography
- 13 September 2005
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (11) , 1520-1521
- https://doi.org/10.1161/circulationaha.105.566182
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- N-Terminal Pro–Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary EmbolismCirculation, 2005
- Thrombolysis in submassive pulmonary embolismJournal of Thrombosis and Haemostasis, 2004
- Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary EmbolismCirculation, 2003
- Still unresolved issues with brain-type natriuretic peptide measurement in the critically ill patient *Critical Care Medicine, 2003
- Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary EmbolismCirculation, 2003
- Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary EmbolismCirculation, 2003
- Low Pro-Brain Natriuretic Peptide Levels Predict Benign Clinical Outcome in Acute Pulmonary EmbolismCirculation, 2003
- Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary EmbolismCirculation, 2002
- Guidelines on diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2000
- Right ventricular dysfunction after acute pulmonary embolism: Pathophysiologic factors, detection, and therapeutic implicationsAmerican Heart Journal, 1995